Developer docs
API playgroundTry for free, no card

Search company profiles

GenePlanet

Full company profile

uuid0002sgi

Namestring
GenePlanet
Legal namestring
GenePlanet
Websiteurl
geneplanet.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

GenePlanet is a Slovenian biotechnology company founded in 2008 and headquartered in Ljubljana that delivers preventive genetic testing and disease prevention services. The company's core offering centers on genetic testing coupled with AI-powered analysis to assess individual health risk and generate personalized recommendations, supported by what the company characterizes as a big data infrastructure for processing genetic information across its geographic footprint. Specific named products, tests, or service tiers are not detailed in the available sources, which focus on funding, partnerships, and market positioning rather than product portfolio granularity.

The business combines direct-to-consumer sales with a B2B channel model, distributing services through healthcare-provider partners — most notably Synlab Hungary — and targeting both individual consumers seeking personalized health insights and medical laboratories or healthcare providers offering genetic testing to patients. Revenue mechanics are described through both one-time and recurring/subscription framings, though pricing is not publicly disclosed. The company is present in over 35 countries, with stated ambitions to reach 50 countries within five years through a mix of direct expansion and channel partnerships in Europe, Latin America, and Asia.

In July 2023, GenePlanet closed a EUR 20 million Series B led by BlackPeak Capital (with participation from Darwin, Fidelity, and Kolektor Ventures), bringing total disclosed funding to roughly USD 34.2M. Proceeds are earmarked for acquisitions, AI development, product portfolio expansion, and international growth, indicating a growth-equity stage company with institutional backing and an aggressive geographic and capability-expansion roadmap. The company is led by founder and CEO Marko Bitenc and operates with 101-250 employees.

Short descriptiontext

GenePlanet is a Slovenian biotech company founded in 2008 that provides AI-powered preventive genetic testing and personalized health risk assessment services to individual consumers and healthcare providers across 35+ countries, with plans to reach 50 markets within five years.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersLjubljana, Slovenia
HQ citystring
Ljubljana
HQ countrystring
Slovenia
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genetic testing services, preventive genomics, personalized medicine, DNA health analysis, disease risk assessment
Industry3 codes
SECONDARYHLAAANAL
Population Genomics & Preventive Precision Health Programs
SECONDARYHLAGADAF
Molecular & Genetic Testing (PCR/NGS/qPCR)
SECONDARYHLAAALAA
Molecular Diagnostics (PCR/qPCR, NGS-based assays)
NAICS code3 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Testing Laboratories8734
Product category
Genetic Testing Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Genetic Testing Services
TypeOne Time License
Description

Direct provision of genetic testing and disease prevention services to individuals and healthcare providers through partnerships and direct channels

bbj.hu
2Healthcare Genetic Testing
TypeSubscription Recurring
Description

Genetic testing and healthcare services across more than 35 countries, with operations in genetic testing and health care sectors

ain.capital
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

GenePlanet is a European biotechnology company that provides preventive genetic testing and disease prevention services. The company analyzes individuals' genetic information using AI-powered systems to deliver personalized health risk assessments and recommendations, and distributes these services both directly to consumers and through partnerships with healthcare providers and laboratories across 35+ countries.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

GenePlanet is a Slovenian biotech company offering genetic testing and disease prevention services. The company provides preventive genetic testing services and healthcare offerings across more than 35 countries. Based on the available source material, no specific named products, modules, or sub-brand offerings are detailed—the sources focus on funding, partnerships, and market expansion rather than product portfolio specifics.

Product and service1 record
1Genetic Testing and Disease Prevention Services
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

GenePlanet partnered with Synlab Hungary to provide genetic testing and disease prevention services in Hungary. This partnership enables GenePlanet to leverage Synlab's healthcare network and laboratory infrastructure to serve the Hungarian market.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors6 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

GenePlanet

Genetic Testing Servicesgeneplanet.com

GenePlanet is a Slovenian biotech company founded in 2008 that provides AI-powered preventive genetic testing and personalized health risk assessment services to individual consumers and healthcare providers across 35+ countries, with plans to reach 50 markets within five years.

What GenePlanet does

GenePlanet is a Slovenian biotechnology company founded in 2008 and headquartered in Ljubljana that delivers preventive genetic testing and disease prevention services. The company's core offering centers on genetic testing coupled with AI-powered analysis to assess individual health risk and generate personalized recommendations, supported by what the company characterizes as a big data infrastructure for processing genetic information across its geographic footprint. Specific named products, tests, or service tiers are not detailed in the available sources, which focus on funding, partnerships, and market positioning rather than product portfolio granularity.

The business combines direct-to-consumer sales with a B2B channel model, distributing services through healthcare-provider partners — most notably Synlab Hungary — and targeting both individual consumers seeking personalized health insights and medical laboratories or healthcare providers offering genetic testing to patients. Revenue mechanics are described through both one-time and recurring/subscription framings, though pricing is not publicly disclosed. The company is present in over 35 countries, with stated ambitions to reach 50 countries within five years through a mix of direct expansion and channel partnerships in Europe, Latin America, and Asia.

In July 2023, GenePlanet closed a EUR 20 million Series B led by BlackPeak Capital (with participation from Darwin, Fidelity, and Kolektor Ventures), bringing total disclosed funding to roughly USD 34.2M. Proceeds are earmarked for acquisitions, AI development, product portfolio expansion, and international growth, indicating a growth-equity stage company with institutional backing and an aggressive geographic and capability-expansion roadmap. The company is led by founder and CEO Marko Bitenc and operates with 101-250 employees.

GenePlanet firmographics

Firmographics
Name
GenePlanet
Legal name
GenePlanet
Website
https://geneplanet.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Short description
GenePlanet is a Slovenian biotech company founded in 2008 that provides AI-powered preventive genetic testing and personalized health risk assessment services to individual consumers and healthcare providers across 35+ countries, with plans to reach 50 markets within five years.
Ownership category
akta.pro rank

Where GenePlanet is headquartered

Location

Headquarters

HQ city
Ljubljana
HQ country
Slovenia
HQ region
Europe

Offices1 record

Markets served

GenePlanet business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. Genetic Testing Services: Direct provision of genetic testing and disease prevention services to individuals and healthcare providers through partnerships and direct channels
  2. Healthcare Genetic Testing: Genetic testing and healthcare services across more than 35 countries, with operations in genetic testing and health care sectors

Go-to-market motion2 records

Distribution channels2 records

Marketing channels1 record

GenePlanet product offering

Product offering

Core offering

GenePlanet is a European biotechnology company that provides preventive genetic testing and disease prevention services. The company analyzes individuals' genetic information using AI-powered systems to deliver personalized health risk assessments and recommendations, and distributes these services both directly to consumers and through partnerships with healthcare providers and laboratories across 35+ countries.

Product overview

GenePlanet is a Slovenian biotech company offering genetic testing and disease prevention services. The company provides preventive genetic testing services and healthcare offerings across more than 35 countries. Based on the available source material, no specific named products, modules, or sub-brand offerings are detailed—the sources focus on funding, partnerships, and market expansion rather than product portfolio specifics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Genetic Testing and Disease Prevention Services

Companies that use GenePlanet

Customer profile

Named customers1 record

Segments2 records

Ideal customer profiles2 records

GenePlanet technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

GenePlanet partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Synlab HungarycoreChannel Partner/ Reseller/ DistributorGenePlanet partnered with Synlab Hungary to provide genetic testing and disease prevention services in Hungary. This partnership enables GenePlanet to leverage Synlab's healthcare network and laboratory infrastructure to serve the Hungarian market.

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

GenePlanet competitors and assessment

Company assessment

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key highlights6 records

Customer concentration

GenePlanet social profiles

Digital presence

GenePlanet financial estimates

Financial estimate

Revenue estimate

Valuation estimate

GenePlanet leadership team

Management profile

Number of profiles

Profiles1 record

GenePlanet funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors6 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

GenePlanet M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GenePlanet

What does GenePlanet do?

GenePlanet is a European biotechnology company that provides preventive genetic testing and disease prevention services. The company analyzes individuals' genetic information using AI-powered systems to deliver personalized health risk assessments and recommendations, and distributes these services both directly to consumers and through partnerships with healthcare providers and laboratories across 35+ countries.

Is GenePlanet a public or private company?

GenePlanet is a private company. It is classified as venture growth investor backed and is currently operating.

When was GenePlanet founded?

GenePlanet was founded in 2008. It employs 101 to 250 people.

Where is GenePlanet based?

GenePlanet is headquartered in Ljubljana, Slovenia, in the Europe region.

How does GenePlanet make money?

Two revenue lines are on record. Genetic Testing Services are the primary driver. The others are healthcare Genetic Testing.

Does GenePlanet have an API?

No public API is recorded for GenePlanet.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
CapitalBlackPeak излиза частично от словенската GenePlanetBlackPeak Capital, a Bulgarian private equity firm, holds a 15.89% stake in Slovenian genetic testing company GenePlanet, acquired in a 2017 round. French-American fund Lauxera Capital Partners is now investing in GenePlanet to expand into Western Europe and the US. The deal includes share buyback and future capital increase options.EU-Startups“Now there is a real chance to become a unicorn”: Slovenia’s GenePlanet secures strategic investment from LauxeraGenePlanet, a Ljubljana-based genomics and laboratory platform, has secured a strategic investment from Lauxera Capital Partners, with existing investor BlackPeak Capital partially exiting while retaining meaningful shareholding. The company, which operates across more than 50 markets and has completed four acquisitions since 2023, will use the capital to expand its proprietary genetic testing portfolio into oncology and rare-disease panels, accelerate entry into Western European and U.S. markets, and pursue further bolt-on acquisitions. GenePlanet, founded in 2008 by Marko Bitenc, aims to achieve unicorn valuation and a full liquidity event for early investors within three to five years.SeeNewsLauxera invests in Slovenia-founded GenePlanetLauxera Capital Partners, a healthtech investor based in Paris and San Francisco, has joined as a shareholder in GenePlanet, a Slovenia-founded provider of clinical and preventive genomics solutions. BlackPeak Capital, which has been GenePlanet's growth partner since 2023, has partially exited its investment as part of the transaction. GenePlanet plans to use the capital to expand its genetic testing portfolio into oncology and rare-disease panels, and to accelerate expansion into Western European and U.S. markets, targeting a full liquidity event for early investors within three to five years.Geneplanet» Lauxera joins GenePlanet as a strategic investor to support the next phase of global growthLauxera Capital Partners joined GenePlanet as a strategic investor, while BlackPeak Capital partially exited its stake. GenePlanet expanded from 24 to over 50 markets and completed four acquisitions over three years. The new capital aims to accelerate expansion into Western Europe and the U.S., with a liquidity event targeted within three to five years.Blackpeak-CapitalLauxera Capital Partners Invests in GenePlanet to Drive Global Diagnostics Expansion; BlackPeak Capital Partially Exits Following Three Years of Transformative GrowthGenePlanet secured a strategic investment from Lauxera Capital Partners, while BlackPeak Capital partially exited its stake after three years. The company expanded from 24 to over 50 markets, completed four acquisitions, and built a Pan-European laboratory platform. Lauxera aims to accelerate expansion into Western Europe and the U.S., with a target liquidity event within three to five years.LauxeraLauxera Capital Partners Invests in GenePlanet to Drive Global Diagnostics ExpansionGenePlanet secured a strategic investment from Lauxera Capital Partners, while BlackPeak Capital partially exited its stake after three years of growth. The company expanded from 24 to over 50 markets, completed four acquisitions, and built a Pan-European laboratory platform. The new capital aims to accelerate expansion into Western Europe and the U.S., with a target liquidity event within three to five years.Budapest Business JournalGenePlanet, Synlab Partner to Bring Services to HungaryGenePlanet has partnered with Synlab Hungary to introduce genetic screening and disease prevention services to the Hungarian market. This expansion is supported by a EUR 20 million investment from BlackPeak Capital, which will also fund the development of an AI system for genome interpretation and further global growth.CapitalБългарският фонд BlackPeak добави словенска компания за генетични тестове в портфейла сиBulgarian investment fund BlackPeak Capital, alongside three partners, invested 20 million euros in Slovenian genetic testing company GenePlanet. The capital will be used by GenePlanet to acquire competitors and expand into Latin American and Asian markets.SeeNewsBulgaria's BlackPeak Capital leads fund-raiser for Slovenian biotech GenePlanetBulgarian growth equity investor BlackPeak Capital led a 20 million euro Series B funding round for Slovenian biotechnology firm GenePlanet. The capital will be used to expand GenePlanet's product portfolio, pursue acquisitions in medical DNA testing, and develop AI systems for human genome interpretation. This investment supports the company's goal of establishing profitable operations in fifty countries within five years.AinSlovenian biotech GenePlanet receives €20M in Series B led by BlackPeak Capital – AIN.CapitalGenePlanet, a Slovenian biotech firm specializing in genetic testing, has secured €20 million in funding from BlackPeak Capital and other investors to enhance product development and big data infrastructure. The investment will support GenePlanet's offerings in preventive genetic tests, including NIPT and cancer screening, as it collaborates with over 1000 medical centers across more than 35 countries.